Review
Accepted on 11 Nov 2024
Innate Immune Cells in the Pathogenesis of Inflammatory Bowel Disease - From Microbial Metabolites to Immune Modulation
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1452430
Type at least 3 characters
23 articles
Articles
Review
Published on 15 Jul 2024
Molecular tools of antibiotic resistance for Helicobacter pylori: an overview in Latin America
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1410816
- 764 views
Mini Review
Accepted on 01 Jul 2024
Synergy of H. Pylori and HIV Coinfection
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1404048
- 155 views
Review
Published on 04 Mar 2024
Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseases
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1331330
- 1,490 views
Editorial
Published on 13 Nov 2023
Editorial: Exploring the interplay between clinical and non-clinical outcomes for children and adults with inflammatory bowel disease
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1311951
- 690 views
Perspective
Published on 01 Nov 2023
Fecal microbiota transplantation—could stool donors’ and receptors’ diet be the key to future success?
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1270899
- 1,351 views
- 1 citation
Editorial
Published on 24 Oct 2023
Editorial: Benefiting from microbes: challenges in getting the ‘pros’ and avoiding the ‘cons’
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1293448
- 744 views
Review
Published on 16 Oct 2023
The potential links between human gut microbiota and cardiovascular health and disease - is there a gut-cardiovascular axis?
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1235126
- 1,682 views
Original Research
Published on 14 Sep 2023
Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1245993
- 2,435 views
Review
Published on 16 Aug 2023
The effect of novel antimicrobial agents on the normal functioning of human intestinal microbiota: a systematic review
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1159352
- 1,324 views
- 1 citation
Case Report
Published on 11 Apr 2023
Case report: Anal tuberculosis presenting as an anal fistula
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1129715
- 3,566 views
- 1 citation
Original Research
Published on 24 Jan 2023
Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2022.1076788
- 2,226 views
- 1 citation
Original Research
Published on 22 Dec 2022
Differences by transplant type in stool multiplex PCR testing for acute diarrhea in post-solid organ transplantation
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2022.1064187
- 1,067 views
Original Research
Published on 15 Dec 2022
Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-up
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2022.1063325
- 1,640 views
Mini Review
Published on 07 Nov 2022
”Sociobiome”: How do socioeconomic factors influence gut microbiota and enhance pathology susceptibility? - A mini-review
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2022.1020190
- 4,014 views
- 9 citations
Review
Published on 25 Oct 2022
Akkermansia muciniphila: The state of the art, 18 years after its first discovery
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2022.1024393
- 13,386 views
- 9 citations